ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $53.40 and traded as high as $56.15. ProShares Ultra Nasdaq Biotechnology shares last traded at $55.17, with a volume of 9,601 shares trading hands.
ProShares Ultra Nasdaq Biotechnology Stock Performance
The stock has a 50-day moving average price of $53.40 and a 200 day moving average price of $59.54.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were given a dividend of $0.3964 per share. The ex-dividend date was Monday, December 23rd. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.
Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Stories
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- What is the Nasdaq? Complete Overview with History
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- How to Buy Cheap Stocks Step by Step
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- There Are Different Types of Stock To Invest In
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.